BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 17205319)

  • 1. Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers.
    Giménez S; Clos S; Romero S; Grasa E; Morte A; Barbanoj MJ
    Psychopharmacology (Berl); 2007 Mar; 190(4):507-16. PubMed ID: 17205319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
    Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
    Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients.
    Sharpley AL; Bhagwagar Z; Hafizi S; Whale WR; Gijsman HJ; Cowen PJ
    J Clin Psychiatry; 2003 Feb; 64(2):192-6. PubMed ID: 12633128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep disturbances in patients with schizophrenia : impact and effect of antipsychotics.
    Cohrs S
    CNS Drugs; 2008; 22(11):939-62. PubMed ID: 18840034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine.
    Walther S; Moggi F; Horn H; Moskvitin K; Abderhalden C; Maier N; Strik W; Müller TJ
    J Clin Psychopharmacol; 2014 Feb; 34(1):124-8. PubMed ID: 24346752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of second generation antipsychotic drugs on sleep variables in healthy subjects and patients with schizophrenia.
    Monti JM; Torterolo P; Pandi Perumal SR
    Sleep Med Rev; 2017 Jun; 33():51-57. PubMed ID: 27321864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.
    Artaloytia JF; Arango C; Lahti A; Sanz J; Pascual A; Cubero P; Prieto D; Palomo T
    Am J Psychiatry; 2006 Mar; 163(3):488-93. PubMed ID: 16513871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder.
    Saletu-Zyhlarz G; Anderer P; Brandstätter N; Dantendorfer K; Gruber G; Mandl M; Ritter K; Zoghlami A; Saletu B
    Neuropsychobiology; 2000; 41(3):139-48. PubMed ID: 10754428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of placebo administration on the first-night effect in healthy young volunteers.
    Suetsugi M; Mizuki Y; Yamamoto K; Uchida S; Watanabe Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):839-47. PubMed ID: 17328999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparison of the effect of the antipsychotics haloperidol and olanzapine on sleep in mania.
    Moreno RA; Hanna MM; Tavares SM; Wang YP
    Braz J Med Biol Res; 2007 Mar; 40(3):357-66. PubMed ID: 17334533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effect of haloperidol, olanzapine, and risperidone on plasma prolactin levels in patients with first-episode psychosis.
    Pérez-Iglesias R; Mata I; Martínez-García O; Garcia-Unzueta MT; Amado JA; Valdizán EM; Vázquez-Barquero JL; Crespo-Facorro B
    J Clin Psychopharmacol; 2012 Dec; 32(6):804-8. PubMed ID: 23131886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo.
    Sharpley AL; Vassallo CM; Cowen PJ
    Biol Psychiatry; 2000 Mar; 47(5):468-70. PubMed ID: 10704958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in sleep after a single oral morning dose of olanzapine in healthy volunteers.
    Giménez S; Romero S; Gich I; Clos S; Grasa E; Antonijoan RM; Barbanoj MJ
    Hum Psychopharmacol; 2011 Oct; 26(7):498-507. PubMed ID: 21953682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia.
    Keefe RS; Young CA; Rock SL; Purdon SE; Gold JM; Breier A;
    Schizophr Res; 2006 Jan; 81(1):1-15. PubMed ID: 16202565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of risperidone on polysomnography in patients with first-episode schizophrenia].
    Chen XS; Zhang MD; Lou FY; Wang HX; Wang JJ; Liang JH; Chen C; Chen XW; Liu L; Gao CY; Liu P; Liu XW
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2467-70. PubMed ID: 17156674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of paradoxical insomnia with atypical antipsychotic drugs. A comparison of olanzapine and risperidone.
    Khazaie H; Rezaie L; Darvishi F; Najafi F; Avis K
    Neurosciences (Riyadh); 2013 Jan; 18(1):64-9. PubMed ID: 23291800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium.
    Grover S; Kumar V; Chakrabarti S
    J Psychosom Res; 2011 Oct; 71(4):277-81. PubMed ID: 21911107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol.
    Yamashita H; Morinobu S; Yamawaki S; Horiguchi J; Nagao M
    Psychiatry Res; 2002 Mar; 109(2):137-42. PubMed ID: 11927138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No negative symptoms in healthy volunteers after single doses of amisulpride, aripiprazole, and haloperidol: a double-blind placebo-controlled trial.
    Park CH; Park TW; Yang JC; Lee KH; Huang GB; Tong Z; Park MS; Chung YC
    Int Clin Psychopharmacol; 2012 Mar; 27(2):114-20. PubMed ID: 22241281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waking and sleep electroencephalogram variables as human sleep homeostatic process biomarkers after drug administration.
    Giménez S; Romero S; Mañanas MA; Barbanoj MJ
    Neuropsychobiology; 2011; 63(4):252-60. PubMed ID: 21494053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.